Media Coverage

VistaGen to study dyskinesia drug in Phase II Parkinson’s trial

VistaGen to study dyskinesia drug in Phase II Parkinson’s trial

Jan 31, 2020

FDA Clears Study to Test New Drug to Treat Dyskinesia for Parkinson Patients

FDA Clears Study to Test New Drug to Treat Dyskinesia for Parkinson Patients

Jan 30, 2020

Intranasal Therapy Fast-Tracked for Social Anxiety Disorder

Intranasal Therapy Fast-Tracked for Social Anxiety Disorder

Dec 19, 2019

Long-Term Use of Benzodiazepines – Avoiding Another Drug Crisis

Long-Term Use of Benzodiazepines – Avoiding Another Drug Crisis

Nov 20, 2019

Advancing AV-101

Advancing AV-101

Aug 28, 2019

PH10 – Nasal spray that works like spritzers to the brain

PH10 – Nasal spray that works like spritzers to the brain

Aug 13, 2019

Living with Social Anxiety Disorder: Uncovering Next – Generation Treatments for a Common and Debilitating Mental Illness

Living with Social Anxiety Disorder: Uncovering Next – Generation Treatments for a Common and Debilitating Mental Illness

Jul 16, 2019

Looking Beyond Current Treatments for CNS Diseases and Disorders

Looking Beyond Current Treatments for CNS Diseases and Disorders

Jul 11, 2019

Going all the way, NMDA work sped up as chances weighed for big players

Going all the way, NMDA work sped up as chances weighed for big players

May 24, 2019

Nasal Spray Research Moves to Social Anxiety Disorder

Nasal Spray Research Moves to Social Anxiety Disorder

Apr 24, 2019